Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL).
Authors
Bloor, AdrianDe Cock, E
Hatswell, A
Wasiak, R
Elvidge, J
Stapelkamp, C
Hadjivassileva, T
Haiderali, A
Delgado, J
Affiliation
Department of Haematology, The Christie NHS Foundation Trust, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.Issue Date
2014-11-20
Metadata
Show full item recordCitation
Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia (DR-CLL). 2014: Br J HaematolJournal
British Journal of HaematologyDOI
10.1111/bjh.13224PubMed ID
25410960Type
ArticleLanguage
enISSN
1365-2141ae974a485f413a2113503eed53cd6c53
10.1111/bjh.13224
Scopus Count
Collections
Related articles
- Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).
- Authors: Hill BT, Caimi P, Kindwall-Keller T, Habecker B, Kalaycio M
- Issue date: 2014 Jan
- Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial.
- Authors: Elter T, Gercheva-Kyuchukova L, Pylylpenko H, Robak T, Jaksic B, Rekhtman G, Kyrcz-Krzemień S, Vatutin M, Wu J, Sirard C, Hallek M, Engert A
- Issue date: 2011 Dec
- Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.
- Authors: Mauro FR, Molica S, Laurenti L, Cortelezzi A, Carella AM, Zaja F, Chiarenza A, Angrilli F, Nobile F, Marasca R, Musolino C, Brugiatelli M, Piciocchi A, Vignetti M, Fazi P, Gentile G, De Propris MS, Della Starza I, Marinelli M, Chiaretti S, Del Giudice I, Nanni M, Albano F, Cuneo A, Guarini A, Foà R, Gruppo Italiano Malattie EMatologiche dell’Adulto Working Party for Chronic Lymphoproliferative Disorders
- Issue date: 2014 Feb
- Outcomes of patients with fludarabine-refractory chronic lymphocytic leukemia: a population-based study from a well-defined geographic region.
- Authors: Eketorp Sylvan S, Hansson L, Karlsson C, Norin S, Lundin J, Osterborg A
- Issue date: 2014 Aug
- How I treat patients with relapsed chronic lymphocytic leukaemia.
- Authors: Cuthill K, Devereux S
- Issue date: 2013 Nov